Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient

Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory illness caused by SARS-CoV-2. Not much is yet known about this new viral disease. In our early encounter with the COVID-19, before the pandemic and during the early days of dealing with this novel viral disease in our country, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Touisserkani, Sam K., Ayatollahi, Azin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415102/
https://www.ncbi.nlm.nih.gov/pubmed/32802540
http://dx.doi.org/10.1155/2020/5892047
_version_ 1783569100974325760
author Touisserkani, Sam K.
Ayatollahi, Azin
author_facet Touisserkani, Sam K.
Ayatollahi, Azin
author_sort Touisserkani, Sam K.
collection PubMed
description Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory illness caused by SARS-CoV-2. Not much is yet known about this new viral disease. In our early encounter with the COVID-19, before the pandemic and during the early days of dealing with this novel viral disease in our country, we saw some cases of anosmia in patients infected by SARS-CoV-2. In many cases, this chemosensitive dysfunction persisted after the negativization of the nasopharyngeal swab. We report effective treatment of anosmia by oral corticosteroid therapy in a patient recovered from COVID-19.
format Online
Article
Text
id pubmed-7415102
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-74151022020-08-14 Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient Touisserkani, Sam K. Ayatollahi, Azin Case Rep Otolaryngol Case Report Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory illness caused by SARS-CoV-2. Not much is yet known about this new viral disease. In our early encounter with the COVID-19, before the pandemic and during the early days of dealing with this novel viral disease in our country, we saw some cases of anosmia in patients infected by SARS-CoV-2. In many cases, this chemosensitive dysfunction persisted after the negativization of the nasopharyngeal swab. We report effective treatment of anosmia by oral corticosteroid therapy in a patient recovered from COVID-19. Hindawi 2020-08-08 /pmc/articles/PMC7415102/ /pubmed/32802540 http://dx.doi.org/10.1155/2020/5892047 Text en Copyright © 2020 Sam K. Touisserkani and Azin Ayatollahi. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Touisserkani, Sam K.
Ayatollahi, Azin
Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient
title Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient
title_full Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient
title_fullStr Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient
title_full_unstemmed Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient
title_short Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient
title_sort oral corticosteroid relieves post-covid-19 anosmia in a 35-year-old patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415102/
https://www.ncbi.nlm.nih.gov/pubmed/32802540
http://dx.doi.org/10.1155/2020/5892047
work_keys_str_mv AT touisserkanisamk oralcorticosteroidrelievespostcovid19anosmiaina35yearoldpatient
AT ayatollahiazin oralcorticosteroidrelievespostcovid19anosmiaina35yearoldpatient

Ejemplares similares